Knak, T.; Abdullaziz, M.A.; Höfmann, S.; Alves Avelar, L.A.; Klein, S.; Martin, M.; Fischer, M.; Tanaka, N.; Kurz, T.
Over 40 Years of Fosmidomycin Drug Research: A Comprehensive Review and Future Opportunities. Pharmaceuticals 2022, 15, 1553.
https://doi.org/10.3390/ph15121553
AMA Style
Knak T, Abdullaziz MA, Höfmann S, Alves Avelar LA, Klein S, Martin M, Fischer M, Tanaka N, Kurz T.
Over 40 Years of Fosmidomycin Drug Research: A Comprehensive Review and Future Opportunities. Pharmaceuticals. 2022; 15(12):1553.
https://doi.org/10.3390/ph15121553
Chicago/Turabian Style
Knak, Talea, Mona A. Abdullaziz, Stefan Höfmann, Leandro A. Alves Avelar, Saskia Klein, Matthew Martin, Markus Fischer, Nobutada Tanaka, and Thomas Kurz.
2022. "Over 40 Years of Fosmidomycin Drug Research: A Comprehensive Review and Future Opportunities" Pharmaceuticals 15, no. 12: 1553.
https://doi.org/10.3390/ph15121553
APA Style
Knak, T., Abdullaziz, M. A., Höfmann, S., Alves Avelar, L. A., Klein, S., Martin, M., Fischer, M., Tanaka, N., & Kurz, T.
(2022). Over 40 Years of Fosmidomycin Drug Research: A Comprehensive Review and Future Opportunities. Pharmaceuticals, 15(12), 1553.
https://doi.org/10.3390/ph15121553